InsidersTradesSigma
Explore the full record of transactions filed by Michael Häggman, Director. Director active across 2 companies, notably Prostatype Genomics AB. Cumulatively, 2 reports have been recorded. The latest transaction was disclosed on 3 October 2025 — Purchase. Regulator: FIN-FSA. All data is accessible without signup.
2 of 2 declarations
Michael Häggman is a Board Member of Prostatype Genomics AB. In this role, he participates in strategic decisions and oversees the company's operations. Michael brings his expertise and experience to support management in achieving Prostatype's objectives. His commitment to good governance is essential for the company's success.